Veracyte and MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System
Go back to Veracyte and MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System| VERACYTE (NASDAQ: VCYT) | Delayed: 47.42 -0.75 (1.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.17 | 52 Week High | $8.45 | |||
| Open | $48.63 | 52 Week Low | $4.21 | |||
| Day High | $48.63 | P/E | N/A | |||
| Day Low | $46.76 | EPS | $-1.52 | |||
| Volume | 1,043,406 | |||||
